Adage Capital Partners
LRMR icon

Adage Capital Partners’s Larimar Therapeutics LRMR Stock Holding History

Adage Capital Partners’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-300,000
Closed -$1.35M – 1052
2026
Q1 		$1.35M Buy
+300,000
New +$1.2M ﹤0.01% 864
2025
Q4 		– Sell
-1,900,000
Closed -$6.14M – 966
2025
Q3 		$6.14M Buy
+1,900,000
New +$7.12M 0.01% 710
2025
Q1 		– Sell
-2,100,000
Closed -$8.13M – 903
2024
Q4 		$8.13M Buy
2,100,000
+399,123
+23% +$2.63M 0.01% 654
2024
Q3 		$11.1M Buy
1,700,877
+329,377
+24% +$2.65M 0.02% 587
2024
Q2 		$9.94M Sell
1,371,500
-61,953
-4% -$474K 0.02% 609
2024
Q1 		$10.9M Buy
1,433,453
+156,773
+12% +$1.22M 0.02% 583
2023
Q4 		$5.81M Buy
1,276,680
+100,000
+8% +$337K 0.01% 665
2023
Q3 		$4.65M Buy
1,176,680
+525,000
+81% +$1.99M 0.01% 674
2023
Q2 		$2.04M Hold
651,680
– – ﹤0.01% 741
2023
Q1 		$2.95M Hold
651,680
– – 0.01% 749
2022
Q4 		$2.69M Hold
651,680
– – 0.01% 796
2022
Q3 		$2.08M Buy
651,680
+475,000
+269% +$1.19M 0.01% 854
2022
Q2 		$346K Hold
176,680
– – ﹤0.01% 950
2022
Q1 		$716K Hold
176,680
– – ﹤0.01% 945
2021
Q4 		$1.91M Hold
176,680
– – ﹤0.01% 873
2021
Q3 		$2.04M Buy
176,680
+100,000
+130% +$1.2M ﹤0.01% 894
2021
Q2 		$753K Buy
+76,680
New +$866K ﹤0.01% 919

Other funds holding LRMR

Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Adage Capital Partners's LRMR Position: Q2 2026 in Review

Adage Capital Partners sold out of Larimar Therapeutics (LRMR) in Q2 2026, closing a stake of 300,000 shares — an estimated $1.35M sold.

Adage Capital Partners first reported a position in LRMR in Q2 2021 and held it in 17 quarters. The position peaked at $11.1M in Q3 2024. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Adage Capital Partners reported no remaining Larimar Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Adage Capital Partners sold 300,000 Larimar Therapeutics shares in Q2 2026, an estimated $1.35M.
  • Adage Capital Partners first reported a position in Larimar Therapeutics in Q2 2021 and held it in 17 quarters.
  • Adage Capital Partners's Larimar Therapeutics position peaked at $11.1M in Q3 2024.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.